Compare LTC Properties Inc (LTC) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
LTC Properties Inc vs Summit Therapeutics Inc — how do they compare? LTC Properties Inc trades at $41.74 (market cap $2.15B), while Summit Therapeutics Inc trades at $14.57 (market cap $10.48B). The key difference: Summit Therapeutics Inc is far larger — about 4.9× LTC Properties Inc's market cap, and LTC Properties Inc pays a 5.44% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| LTC | SMMT | |
|---|---|---|
Market Cap | $2.15B | $10.48B |
Sector | Real Estate | Health |
52-Week High | $41.92 | $29.32 |
52-Week Low | $33.98 | $13.05 |
Enterprise Value | $2.99B | $9.90B |
Dividend Yield | 5.44% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About LTC Properties Inc
LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in healthcare facilities through mortgage loans, property lease transactions, and other investments. LTC generates all of its revenue in the United States. LTC is an active capital provider in the seniors housing and health care real estate industry. The company has been actively engaged with its operating partners to create a growing pipeline of projects. LTC considers merger and acquisition investment as a component of its operational growth strategy.
Read more on LTC →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
